Purchase 2-PTC
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 2-PTC for sale
2-P-Tolyl- Cyclopropanamine is a new synthetic psychoactive substance (NPS) legally available in the E.U., U.S., Canada, and elsewhere. While there are several different names for 2-P-Tolyl- Cyclopropanamine, we refer to it as 2-PTC in this document.
This agent is also known as 2-(4-methyl phenyl)-hydrochloride and sells as a white powder and is the newest chemical substance on the market of chemical products. Some other names that may be used for this substance are Cyclopropanamine and R-MDMA; some users come across 2-p-Tolyl- Cyclopropanamine.
2-PTC was designed to be a less toxic analogue of MDA. However, 2-PTC has turned out to be not only more toxic than MDA but also more toxic than MDMA itself. The full name of 2-PTC is 2-(4-methyl phenyl)-hydrochloride. It sells as a white powder and is the newest chemical substance on the market of chemical products. Some other names that may be used for this substance are Cyclopropanamine and R-MDMA. Some users come across 2-p-Tolyl- Cyclopropanamine in their research papers or hear about it as a chemical compound that can produce an effect similar to ecstasy or other drugs.
It's a chemical compound that consists of Phenyl-2-Propanamine (R-MDMA), an analogue of MDA and cyclopropanation. The full name of 2-PTC is 2-(4-methyl phenyl)-hydrochloride.
2-PTC hydrochloride, or 2-(4-methyl phenyl)-hydrochloride, also called Cyclopropanamine) is a designer drug and member of the benzodifuranylethylamine class of compounds. It has been sold online as a designer drug starting in 2012.
2-(4-methyl phenyl)-hydrochloride (2-PTC) is a chemical substance that produces amphetamine-like effects.
2-PTC is a central nervous system stimulant that acts by increasing the activity of several neurotransmitters and monoamine oxidase inhibitors in the brain and blocking the reuptake of dopamine and norepinephrine.
The psychotropic substance 2-PTC is a novel compound developed by G.Fiori in 2005 and is of the Clopropanamine class.
2-PTC (2-(4-methyl phenyl)-hydrochloride) is the newest chemical substance on the market of chemical products. Some other names that may be used for this substance are Cyclopropanamine and R-MDMA. Some users come across 2-p-Tolyl- Cyclopropanamine.
2-PTC is a potent stimulant with stimulating properties similar to those cocaine. It is known for producing high dopamine, serotonin and norepinephrine levels, along with various cognitive and physical effects.
The two-carbon homologue of phenethylamine, 2-Phenylethylamine, also known as 2-Acetylmorpholine, is a research chemical that acts as an NRI that is similar in effects to cocaine.
2-Phenethylamine, also known as 2-PTC, is a research chemical and derivative of phenethylamine and amphetamine. It acts as a releasing agent for norepinephrine and dopamine and has been reported to be a reasonably potent monoamine releaser with EC50 values around 20 µM. Its effects are described similarly to other substituted amphetamines; it produces intense euphoria and energy, heightened self-awareness, enhanced tactile sensations, and a desire to communicate with others.
2-Bromo-4,5-dimethoxy-phenethylamine (also known as Bromo-DragonFly, 2C-B or colloquially as Bromo) is a psychedelic substance of the phenethylamine class. It produces an array of visually striking and psychotropic effects when administered. Its appearance is similar to LSD, though more visual in nature rather than psychedelic. It was first synthesised by Alexander Shulgin, though it was briefly mentioned in patents filed years earlier. 2C-B has been used as an entheogen by scientific and medical community members and is still available by request on the Research Chemical Mailing List; however, it is also sold as a recreational drug.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
200g $690
out of stock
out of stock
1kg $1690
1kg $1590
100mg $840
500g $1080
100g $600
out of stock
100mg $840
1000 pills $45
1kg $1690